Aller au contenu

Products
- Mega-Menu
  Transplantation
  
  Transplantation
  
  The group produces reagents and software for transplant matching, chimerism monitoring and culture media for cornea graft transplants.
  
  GenDx Products
  
  Cornea
  
  Our suppliers (FR/US only)
  
  Oncology
  
  Oncology
  
  Eurobio Scientific manufactures prognostic genomic tests for breast cancer and prostate cancer.
  
  EndoPredict® & Prolaris®
  
  Our suppliers (FR only)
  
  Infectious Diseases
  
  Infectious Diseases
  
  The group develops and markets genetic molecular tests to detect a wide variety of illnesses, including detecting infectious diseases, fertility testing or assaying dermatological conditions
  
  EurobioPlex
  
  TECO® FungiLine
  
  TQS
  
  Our suppliers (FR only)
  
  Life Sciences
  
  Life Sciences
  
  To support the research and development field, Eurobio Scientific has a broad portfolio in Life Science products including cell culture media and quality controls.
  
  Cell culture
  
  Biosafety PKA
  
  ELISA
  
  Molecular Biology
  
  Immunology
  
  Our suppliers (FR only)
  
  Quality Control
  
  Quality Control
  
  The controls for auto-immunity and allergy are multi-analyte controls, which offers a the possibility of testing different analytes in parallel by using only one control.
  
  PathTROL™ Quality Controls
  
  Our suppliers (FR only)
  
  Other
  
  Other
  
  Product Index
  
  Downloads
  
  Certificates
  
  Contact Us
  
  FAQs
About Us
Investors
- General
- Investors
Join Us

Products
- Mega-Menu
  Transplantation
  
  Transplantation
  
  The group produces reagents and software for transplant matching, chimerism monitoring and culture media for cornea graft transplants.
  
  GenDx Products
  
  Cornea
  
  Our suppliers (FR/US only)
  
  Oncology
  
  Oncology
  
  Eurobio Scientific manufactures prognostic genomic tests for breast cancer and prostate cancer.
  
  EndoPredict® & Prolaris®
  
  Our suppliers (FR only)
  
  Infectious Diseases
  
  Infectious Diseases
  
  The group develops and markets genetic molecular tests to detect a wide variety of illnesses, including detecting infectious diseases, fertility testing or assaying dermatological conditions
  
  EurobioPlex
  
  TECO® FungiLine
  
  TQS
  
  Our suppliers (FR only)
  
  Life Sciences
  
  Life Sciences
  
  To support the research and development field, Eurobio Scientific has a broad portfolio in Life Science products including cell culture media and quality controls.
  
  Cell culture
  
  Biosafety PKA
  
  ELISA
  
  Molecular Biology
  
  Immunology
  
  Our suppliers (FR only)
  
  Quality Control
  
  Quality Control
  
  The controls for auto-immunity and allergy are multi-analyte controls, which offers a the possibility of testing different analytes in parallel by using only one control.
  
  PathTROL™ Quality Controls
  
  Our suppliers (FR only)
  
  Other
  
  Other
  
  Product Index
  
  Downloads
  
  Certificates
  
  Contact Us
  
  FAQs
About Us
Investors
- General
- Investors
Join Us

Products
- Mega-Menu
  Transplantation
  
  Transplantation
  
  The group produces reagents and software for transplant matching, chimerism monitoring and culture media for cornea graft transplants.
  
  GenDx Products
  
  Cornea
  
  Our suppliers (FR/US only)
  
  Oncology
  
  Oncology
  
  Eurobio Scientific manufactures prognostic genomic tests for breast cancer and prostate cancer.
  
  EndoPredict® & Prolaris®
  
  Our suppliers (FR only)
  
  Infectious Diseases
  
  Infectious Diseases
  
  The group develops and markets genetic molecular tests to detect a wide variety of illnesses, including detecting infectious diseases, fertility testing or assaying dermatological conditions
  
  EurobioPlex
  
  TECO® FungiLine
  
  TQS
  
  Our suppliers (FR only)
  
  Life Sciences
  
  Life Sciences
  
  To support the research and development field, Eurobio Scientific has a broad portfolio in Life Science products including cell culture media and quality controls.
  
  Cell culture
  
  Biosafety PKA
  
  ELISA
  
  Molecular Biology
  
  Immunology
  
  Our suppliers (FR only)
  
  Quality Control
  
  Quality Control
  
  The controls for auto-immunity and allergy are multi-analyte controls, which offers a the possibility of testing different analytes in parallel by using only one control.
  
  PathTROL™ Quality Controls
  
  Our suppliers (FR only)
  
  Other
  
  Other
  
  Product Index
  
  Downloads
  
  Certificates
  
  Contact Us
  
  FAQs
About Us
Investors
- General
- Investors
Join Us

Products
- Mega-Menu
  Transplantation
  
  Transplantation
  
  The group produces reagents and software for transplant matching, chimerism monitoring and culture media for cornea graft transplants.
  
  GenDx Products
  
  Cornea
  
  Our suppliers (FR/US only)
  
  Oncology
  
  Oncology
  
  Eurobio Scientific manufactures prognostic genomic tests for breast cancer and prostate cancer.
  
  EndoPredict® & Prolaris®
  
  Our suppliers (FR only)
  
  Infectious Diseases
  
  Infectious Diseases
  
  The group develops and markets genetic molecular tests to detect a wide variety of illnesses, including detecting infectious diseases, fertility testing or assaying dermatological conditions
  
  EurobioPlex
  
  TECO® FungiLine
  
  TQS
  
  Our suppliers (FR only)
  
  Life Sciences
  
  Life Sciences
  
  To support the research and development field, Eurobio Scientific has a broad portfolio in Life Science products including cell culture media and quality controls.
  
  Cell culture
  
  Biosafety PKA
  
  ELISA
  
  Molecular Biology
  
  Immunology
  
  Our suppliers (FR only)
  
  Quality Control
  
  Quality Control
  
  The controls for auto-immunity and allergy are multi-analyte controls, which offers a the possibility of testing different analytes in parallel by using only one control.
  
  PathTROL™ Quality Controls
  
  Our suppliers (FR only)
  
  Other
  
  Other
  
  Product Index
  
  Downloads
  
  Certificates
  
  Contact Us
  
  FAQs
About Us
Investors
- General
- Investors
Join Us

Eurobio Scientific Team

Press releases

Replacement of a Statutory Auditor

December 22,2025

Results for the first semester of fiscal year 2025

September 24, 2025

Eurobio Scientific completes the acquisition of Life Science unit of Voden Medical Instruments Spa in Italy

July 1st, 2025

Resultat Annuel 2024 - Growth of core business and strategic execution

April 28, 2025

Eurobio Scientific increases its footprint in Italy

March 12, 2025

Termination of the liquidity contract

March 3, 2025

French only

Calendar of financial publications 2025

Janvier 15, 2025 (FR)

French only

Archive

2024

Eurobio Scientific: successful takeover bid at the end of its first period, reopening of the offer from 4 to 17 December

November 29, 2024 (FR)

French only

Opening of the public purchase offer until November 27

October 24, 2024 (FR)

French only

Eurobio Scientific: lifting of the last regulatory suspensive condition to the takeover bid project initiated by EB Development

October 16, 2024 (FR)

French only

Results for the first half of 2024

September 24, 2024

Eurobio Scientific completes acquisition of Endopredict® genomic test from Myriad Genetics

August 2, 2024

Suspension of the liquidity contract

August 1, 2024 (FR)

French only

First half 2024, a solid start of the financial year in an uncertain environment - PROPOSED TENDER OFFER

July 31, 2024

Agreement to acquire the ENDOPREDICT gene expression test for breast cancer

May 7, 2024

Publication of the 2023 financial annual report

April 26, 2024 (FR)

French only

2023 annual results, growth in Core Business and strategic deployment

April 9, 2024

2023 Annuel revenue at 130,1 MEUR

January 30, 2024

Capital reduction through cancellation of treasury shares-2024

January 9, 2024

2023

Catherine Courboillet to join the Board as an Independant Member

November 7, 2023

Availability of the 2023 half-yearly financial report

October 30, 2023 (FR)

French only

GenDx reduces organ matching time to 3 hours

October 17, 2023

French only

H1 2023 Results: Solid performance of Core Business and acceleration of strategic deployment

October 11, 2023

Acceleration of strategic deployment in the first half of 2023

July 24, 2023

Capital reduction through cancellation of treasury shares

July 11, 2023

All resolutions approved at the 2023 Annual General Meeting - The Board of Directors appoints a new governance

June 16, 2023

Acquisition of D.I.D. in Italy

June 13, 2023

First IVDR CE marking of PCR tests

May 23, 2023

Publication of the 2022 annual financial report

April 28, 2023 (FR)

2022 annual results : very strong performance and strengthening of the Core Business

April 5, 2023

Wietse Mulder, CEO of GenDx, holds a 2% stake in Eurobio Scientific

February 14, 2023

Eurobio Scientific formalises the appointment of Anne-Sophie Herelle as Group CFO

February 8, 2023

2022 annual turnover of €152.5M

January 23, 2023

H2 2022 report on the liquidity contract

January 5, 2023 (FR)

2022

Exclusive commercial agreement for the distribution of a diagnostic test that predicts response to a treatment for pancreatic cancer

November 22, 2022

Half-year financial report available

October 27, 2022 (FR)

H1 2022 Results: continued growth of non-COVID activity

October 11, 2022

Eurobio Scientific finalizes the acquisition of GenDx, international HLA diagnostics specialist

October 3, 2022

Eurobio Scientific signs an agreement to acquire GenDx, international HLA diagnostics specialist

August 17, 2022

First half turnover of €83.6 million maintained at a high level

July 25, 2022

Half-year report on liquidity contract

July 11, 2022 (FR)

Launch of 2 new proprietary tests : new variants of SARS-CoV-2, and Monkeypox

June 20, 2022

Eurobio Scientific's annual shareholders' meeting

June 14, 2022 (FR)

Eurobio Scientific expands into Benelux by acquiring the diagnostic company Biomedical Diagnostics NV

June 13, 2022

Closing of the Strategic Partnership with NEXTSTAGE AM

May 18, 2022

Availability of the 2021 annual financial report

April 28, 2022 (FR)

Eurobio Scientific partners with Dr. Nino Guy Cassuto for the development of a new PCR test for male fertility

April 26, 2022

CE mark for Eurobio Scientific’s new proprietary test for the detection of Omicron BA.x, BA.2 and Delta variants of SARS-CoV-2

April 14, 2022

Maintaining high level results in 2021

April 6, 2022

New priority test for the detection of Omicron BA.x, BA.2 and Delta of SARS-CoV-2

February 7, 2022

Strategic partnership with NextStage AM

February 7, 2022

2021 TURNOVER : Exceptional level of €184.1million

January 24, 2022

Eurobio Scientific launches the exclusive distribution of the first saliva self-test for HIV testing in France

January 11, 2022

Eurobio Scientific confirms its eligibility to the pea-pme system

January 10, 2022 (FR)

You may also like

Meet the management team behind Eurobio Scientific Group!

December 22, 2025

Eurobio Scientific Group acquire the assets of the Life Science unit of Voden Medical Instruments S.p.A.

March 19, 2025

Eurobio Scientific Group has successfully completed the acquisition of Quimark SRL

March 19, 2025

Eurobio Scientific Expands Oncology Portfolio with Biovica Partnership

March 5, 2025

EBX 071 Achieves CE-IVDR Certification

February 25, 2025

First IVDR CE marking of PCR tests

January 6, 2025

Join Us
Contact Us
Product Index
Downloads
News
Press releases
FAQs
Registration
Privacy Policy
Cookie Policy

EurobioPlex
GenDx
Cornea
TECO® FungiLine
TQS
Cell Culture
Quality Control
Immunology
Molecular Biology
Biosafety PKA

Eurobio Scientific © 2026 / EVRY 389 318 023 / TVA FR 414 488 171

Search

We've detected you might be speaking a different language. Do you want to change to:

Change Language

Close and do not switch language

Cookies Policy

This Privacy Policy informs you about the manner in which Eurobio Scientific collects and processes personal data concerning you via its website www.eurobio-scientific.com (hereinafter the Website) as data controller within the meaning of the provisions of the General Data Protection Regulation No. 2016/679 of 27 April 2016 (“GDPR”) and the Data Protection Act No. 78-17 of 6 January 1978 (hereinafter together referred to as the “Regulations”).

Functional Functional Always active

This Privacy Policy informs you about the manner in which Eurobio Scientific collects and processes personal data concerning you via its website www.eurobio-scientific.com (hereinafter the Website) as data controller within the meaning of the provisions of the General Data Protection Regulation No. 2016/679 of 27 April 2016 (“GDPR”) and the Data Protection Act No. 78-17 of 6 January 1978 (hereinafter together referred to as the “Regulations”).

Preferences Preferences

The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.

Statistics Statistics

The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.

Marketing Marketing

The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.

Manage options
Manage services
Manage {vendor_count} vendors
Read more about these purposes

View preferences

{title}
{title}
{title}

Retour en haut